Michael W. Graner

13.0k total citations · 1 hit paper
94 papers, 5.6k citations indexed

About

Michael W. Graner is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Michael W. Graner has authored 94 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 39 papers in Immunology and 21 papers in Cancer Research. Recurrent topics in Michael W. Graner's work include Extracellular vesicles in disease (25 papers), Immunotherapy and Immune Responses (23 papers) and MicroRNA in disease regulation (16 papers). Michael W. Graner is often cited by papers focused on Extracellular vesicles in disease (25 papers), Immunotherapy and Immune Responses (23 papers) and MicroRNA in disease regulation (16 papers). Michael W. Graner collaborates with scholars based in United States, China and United Kingdom. Michael W. Graner's co-authors include Thomas J. Anchordoquy, Tyson Smyth, Darell D. Bigner, Emmanuel Katsanis, Peter Smith‐Jones, Jasmina S. Redzic, Yi Zeng, Hanping Feng, Noeen Malik and Max Kullberg and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Michael W. Graner

93 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

2014 600 citations Tyson Smyth, Michael W. Graner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael W. Graner United States	38	4.0k	2.0k	1.4k	708	488	94	5.6k
Jeffrey L. Franklin United States	33	5.9k 1.5×	3.2k 1.6×	912 0.7×	799 1.1×	547 1.1×	66	7.0k
Angang Yang China	50	5.1k 1.3×	2.9k 1.4×	1.6k 1.2×	1.5k 2.2×	223 0.5×	230	7.7k
Paule Opolon France	44	3.5k 0.9×	1.3k 0.6×	1.1k 0.8×	1.5k 2.1×	696 1.4×	159	6.6k
James N. Higginbotham United States	26	4.8k 1.2×	2.6k 1.3×	788 0.6×	719 1.0×	471 1.0×	48	5.8k
Mercedes Tkach France	20	7.3k 1.8×	3.9k 1.9×	1.6k 1.1×	506 0.7×	763 1.6×	25	8.3k
Zsuzsanna Tabi United Kingdom	31	3.6k 0.9×	2.0k 1.0×	2.1k 1.5×	854 1.2×	381 0.8×	53	5.5k
An Hendrix Belgium	39	4.9k 1.2×	2.7k 1.3×	714 0.5×	800 1.1×	712 1.5×	96	6.1k
Luana Lugini Italy	31	5.3k 1.3×	3.0k 1.5×	1.6k 1.2×	911 1.3×	722 1.5×	39	6.7k
Lunquan Sun China	42	3.3k 0.8×	1.3k 0.6×	733 0.5×	988 1.4×	268 0.5×	135	5.2k
Alicia Llorente Norway	31	6.5k 1.6×	3.6k 1.8×	966 0.7×	251 0.4×	694 1.4×	67	7.5k

Countries citing papers authored by Michael W. Graner

Since Specialization

Citations

This map shows the geographic impact of Michael W. Graner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Graner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Graner more than expected).

Fields of papers citing papers by Michael W. Graner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Graner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Graner. The network helps show where Michael W. Graner may publish in the future.

Co-authorship network of co-authors of Michael W. Graner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Graner. A scholar is included among the top collaborators of Michael W. Graner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Graner. Michael W. Graner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coughlan, Christina, et al.. (2024). Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanoma. Biochemical and Biophysical Research Communications. 734. 150631–150631. 2 indexed citations

Coughlan, Christina, Robert G. Kowalski, Peter G. E. Kennedy, et al.. (2022). Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles. Biomedicines. 10(11). 2718–2718. 5 indexed citations

Tatman, Philip D., Denise M. Damek, Kevin O. Lillehei, et al.. (2022). Targeting DNA Methyl Transferases with Decitabine in Cultured Meningiomas. World Neurosurgery. 162. e99–e119. 1 indexed citations

Kennedy, Peter G. E., Michael W. Graner, Xiaomeng Li, et al.. (2021). Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis. Journal of Neuroimmune Pharmacology. 17(1-2). 218–227. 18 indexed citations

Kennedy, Peter G. E., et al.. (2020). Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands. Journal of Neuroimmune Pharmacology. 16(3). 567–580. 29 indexed citations

Graner, Michael W., et al.. (2018). Tumor-derived exosomes, microRNAs, and cancer immune suppression. Seminars in Immunopathology. 40(5). 505–515. 71 indexed citations

Spillman, Monique A., Kian Behbakht, Juan E. Abrahante, et al.. (2017). A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis. Analytical Biochemistry. 536. 8–15. 7 indexed citations

Beseler, Cheryl L., Timothy Vollmer, Michael W. Graner, & Xiaoli Yu. (2017). The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution. PLoS ONE. 12(10). e0186842–e0186842. 29 indexed citations

Hellwinkel, Justin E., Helen J. Madsen, Tessa Harland, et al.. (2016). HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*. International Journal of Hyperthermia. 33(3). 303–317. 10 indexed citations

10.

Graner, Michael W.. (2015). The Unfolded Protein Response in Glioblastomas: Targetable Or Trouble?. Future Science OA. 1(2). FSO45–FSO45. 8 indexed citations

11.

Graner, Michael W.. (2015). HSP90 and Immune Modulation in Cancer. Advances in cancer research. 129. 191–224. 61 indexed citations

12.

Smyth, Tyson, Jasmina S. Redzic, Michael W. Graner, & Thomas J. Anchordoquy. (2014). Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1838(11). 2954–2965. 168 indexed citations

13.

Dodd, Rebecca D., Andrea L. Merz, Anjelika Dechkovskaia, et al.. (2013). Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells. PLoS ONE. 8(8). e73267–e73267. 55 indexed citations

14.

Lillehei, Kevin O., et al.. (2013). Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure. International Journal of Hyperthermia. 29(6). 520–527. 8 indexed citations

15.

Qiu, Zhengang, Mingxia Zhang, Yuzhen Zhu, et al.. (2012). Multifunctional CD4 T Cell Responses in Patients with Active Tuberculosis. Scientific Reports. 2(1). 216–216. 57 indexed citations

16.

Chen, Xinchun, Mingxia Zhang, Mingfeng Liao, et al.. (2009). Reduced Th17 Response in Patients with Tuberculosis Correlates with IL-6R Expression on CD4+ T Cells. American Journal of Respiratory and Critical Care Medicine. 181(7). 734–742. 123 indexed citations

17.

Milani, Valeria, Michael W. Graner, Ingo Drexler, et al.. (2008). Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens. International Journal of Hyperthermia. 24(8). 623–637. 11 indexed citations

18.

Ramanathapuram, Lalitha, Tobias Hahn, Michael W. Graner, Emmanuel Katsanis, & Emmanuel T. Akporiaye. (2005). Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines. Cancer Immunology Immunotherapy. 55(2). 166–177. 18 indexed citations

19.

Zeng, Yi, Michael W. Graner, & Emmanuel Katsanis. (2005). Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunology Immunotherapy. 55(3). 329–338. 34 indexed citations

20.

Graner, Michael W., Yi Zeng, Hanping Feng, & Emmanuel Katsanis. (2003). Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology Immunotherapy. 52(4). 226–234. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact